Lost Epigenetic Guardian CBX7 Emerges as Key Driver and Drug Target in Glioblastoma
A new review shows that the epigenetic regulator CBX7 acts as a tumor suppressor in glioblastoma, and that restoring its ...
A new review shows that the epigenetic regulator CBX7 acts as a tumor suppressor in glioblastoma, and that restoring its ...
New research in iScience identifies the blood-brain barrier transporter SLC38A2 as a critical route for dietary L-serine entry into the ...
A new review in Molecular Cancer details how five classes of nanomaterials could breach the blood–brain barrier and dismantle the ...
New research shows that the transcription factor SOX9 primes Hippo–YAP/TAZ pathway rewiring during a narrow early window of stemness acquisition ...
An AI-driven screening pipeline identified the fungal sterol 5,6-epoxyergosterol as a selective LXRβ agonist that exploits the cholesterol dependency of ...
A retrospective study of 185 glioblastoma patients finds that walking ability measured at hospital discharge independently predicts overall survival beyond ...
Researchers found that the RNA acetyltransferase NAT10 helps glioblastoma resist radiotherapy by stabilizing SLC7A11 mRNA and blocking immunogenic ferroptosis, and ...
New research shows that FAP-positive pericyte-like cells in glioblastoma promote the differentiation of monocytes into immunosuppressive tumor-associated macrophages.
Glioblastoma is among the most aggressive and difficult-to-treat brain cancers, and a new study is drawing attention to an unexpected ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine